Potential drugs for the treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

Potential drugs for the treatment of Alzheimer’s disease

Published:2023-04-01 Issue:3 Volume:75 Page:544-559
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacol. Rep

Author:

Montero-Cosme Tania Guadalupe,Pascual-Mathey Luz Irene^ORCID,Hernández-Aguilar María Elena^ORCID,Herrera-Covarrubias Deissy^ORCID,Rojas-Durán Fausto^ORCID,Aranda-Abreu Gonzalo Emiliano^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s43440-023-00481-5.pdf

Reference134 articles.

1. Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res. 2018;7 (F1000 Faculty Rev):1161.

2. Barragán D, Parra A, Tejeiro J. Alzheimer’s disease. Medicine. 2019;12(74):4338–46 (in Spanish).

3. Guan PP, Liang YY, Cao LL, Yu X, Wang P. Cyclooxygenase-2 induced the β-amyloid protein deposition and neuronal apoptosis via upregulating the synthesis of prostaglandin E2 and 15-deoxy-Δ12,14-prostaglandin J2. Neurotherapeutics. 2019;16(4):1255–68.

4. Wu C, Gong WG, Wang YJ, Sun JJ, Zhou H, Zhang ZJ, et al. Escitalopram alleviates stress-induced Alzheimer’s disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity. Neurobiol Aging. 2018;67:137–47.

5. Wang Y, Guan PP, Yu X, Guo YS, Zhang YJ, Wang ZY, et al. COX-2 metabolic products, the prostaglandin I2 and F2α, mediate the effects of TNF-α and Zn2+ in stimulating the phosphorylation of Tau. Oncotarget. 2017;8(59):99296–311.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer’s Disease;Central Nervous System Agents in Medicinal Chemistry;2024-08

2. Neuroprotective effects of chitosan nanoparticles loaded with niruriflavone in an aluminium chloride-induced Alzheimer’s disease rat model;Toxicology and Environmental Health Sciences;2024-03-20

3. Exploration of Molecular Targets and Mechanisms of Curcumin in the Treatment of COVID-19 with Depression by an Integrative Pharmacology Strategy;Current Pharmaceutical Design;2023-09